Protocol Ledger

NCT06099366 · Phase II · RECRUITING

Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in Children

Interventional Phase II clinical trial protocol NCT06099366 sponsored by Hee Young Ju in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-03-05 Enrollment: 116 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06099366
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)116 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06099366
Protocol FieldVerified Registry Value
NCT IdentifierNCT06099366
Consolidated Lead SponsorHee Young Ju
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment116 participants (ESTIMATED)
Registered Start Date2024-03-05
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT06099366
Hospital Research SiteLocationSite Profile
Asan Medical CenterSeoul, South KoreaOpen Hospital Dossier ->
Samsung Medical CenterSeoul, South KoreaOpen Hospital Dossier ->
Pusan National University Yangsan HospitalYangsan, South KoreaOpen Hospital Dossier ->
Kyungpook National University Chilgok HospitalDaegu, South KoreaOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI